Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Agarwal'S Eye HospitalBOM:526783 +0.68%95 Return-on-Tangible-Equity is 20.39% as of Mar. 2026, which is 36% below its 10-year median of 32.10. GuruFocus rates BOM:526783 with a GF Score™ of 95/100 and a GF Value™ of ₹5,371.92 (Fairly Valued). The stock has 3 warning signs investors should review. Among 580 Healthcare Providers & Services companies, Dr Agarwal'S Eye Hospital ranks better than 74.31% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Dr Agarwal'S Eye Hospital's annualized net income for the quarter that ended in Mar. 2026 was ₹650 Mil. Dr Agarwal'S Eye Hospital's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹3,186 Mil. Therefore, Dr Agarwal'S Eye Hospital's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 20.39%.
The historical rank and industry rank for Dr Agarwal'S Eye Hospital's Return-on-Tangible-Equity or its related term are showing as below:
BOM:526783'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -4 Med: 32.1 Max: 44.81
Current: 26.76
During the past 13 years, Dr Agarwal'S Eye Hospital's highest Return-on-Tangible-Equity was 44.81%. The lowest was -4.00%. And the median was 32.10%.
BOM:526783's Return-on-Tangible-Equity is ranked better than 74.31% of 580
companies
in the Healthcare Providers & Services industry
Industry Median: 10.085
vs BOM:526783: 26.76
Dr Agarwal'S Eye Hospital (BOM:526783) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Dr Agarwal'S Eye Hospital Return-on-Tangible-Equity Related Terms
Dr Agarwal'S Eye Hospital Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Dr Agarwal'S Eye Hospital's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Agarwal'S Eye Hospital Return-on-Tangible-Equity Chart
BOM:526783 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Dr Agarwal'S Eye Hospital's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Agarwal'S Eye Hospital Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dr Agarwal'S Eye Hospital's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Dr Agarwal'S Eye Hospital's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 20.39% mean?
Dr Agarwal'S Eye Hospital (BOM:526783) has a Return-on-Tangible-Equity of 20.39% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Dr Agarwal'S Eye Hospital and its competitors. This is 36% below median its historical median of 32.10. According to the industry distribution chart, Dr Agarwal'S Eye Hospital ranks #149 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 25.7%.
Is Dr Agarwal'S Eye Hospital's Return-on-Tangible-Equity too high?
Dr Agarwal'S Eye Hospital's current Return-on-Tangible-Equity of 20.39% is 36% below median its 10-year median of 32.10. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.09. Dr Agarwal'S Eye Hospital's value of 20.39% is 102.2% above this industry median. Based on the distribution chart, Dr Agarwal'S Eye Hospital ranks #149 out of 580 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dr Agarwal'S Eye Hospital has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal'S Eye Hospital's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Agarwal'S Eye Hospital ranks #149 out of 580 companies for Return-on-Tangible-Equity. This puts Dr Agarwal'S Eye Hospital in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.09. Dr Agarwal'S Eye Hospital's value of 20.39% is 102.2% above this benchmark. While the company's 10-year median is 32.10 vs. the industry median of 10.09, Dr Agarwal'S Eye Hospital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.09, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Agarwal'S Eye Hospital's current Return-on-Tangible-Equity of 20.39% is 102.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Dr Agarwal'S Eye Hospital and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Agarwal'S Eye Hospital's current Return-on-Tangible-Equity is 20.39%, which is 36% below median its own 10-year median of 32.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal'S Eye Hospital stock overvalued right now?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital (BOM:526783) is currently considered Fairly Valued. The stock's GF Value™ is ₹5,371.92, compared to a current price of ₹5,005.05 — trading 6.8% below its estimated fair value. The current Return-on-Tangible-Equity is 20.39%, which is 36% below median its 10-year median of 32.10 and 102.2% above the Healthcare Providers & Services industry median of 10.09. Dr Agarwal'S Eye Hospital's overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Dr Agarwal'S Eye Hospital (BOM:526783), the current Return-on-Tangible-Equity is 20.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Agarwal'S Eye Hospital (BOM:526783) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital stock appears to be undervalued.
The current stock price of ₹5,005.05 is trading 6.8% below its estimated GF Value™ of ₹5,371.92.
GuruFocus considers Dr Agarwal'S Eye Hospital to be Fairly Valued.
Key valuation signals for BOM:526783:
Return-on-Tangible-Equity: 20.39% (36% below median its 10-year median of 32.10)
GF Value™: ₹5,371.92 vs. price of ₹5,005.05 (6.8% below fair value)
Industry Position: 102.2% above the Healthcare Providers & Services median (#149 of 580)
No single metric tells the full story. See the BOM:526783 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Agarwal'S Eye Hospital Ltd is a provider of eye care and related services. The company is predominantly engaged in running, owning and managing eye care hospitals, opticals, pharmacies, and related services. It operates across various locations in India and provides solutions like Refractive Surgery, Lasik Surgery, Oculoplasty, Laser Cataract Surgery, and SMILE Eye Surgery among others.
95GF Score
Get the complete analysis for BOM:526783
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526783 has been successfully added to your 
